Print

HVTN 096

Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults

Trial Details:

I Completed
HIV Vaccine Trials Network (HVTN), EuroVac August 01, 2012
AIDSVAX gp120 B/E ,DNA-HIV-PT123,NYVAC-HIV-PT1,NYVAC-HIV-PT4 Protien Env B/E; DNA gag, env, nef, pol C; Pox Env gp140, Gag, Pol-Nef C
DNA-HIV-PT123 DNA
NYVAC-HIV-PT1 Viral Vector - Pox
NYVAC-HIV-PT4 Viral Vector - Pox
Switzerland 96
NCT01799954
http://clinicaltrials.gov/show/NCT01799954